Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот ресурс:
http://elar.urfu.ru/handle/10995/111134
Полная запись метаданных
Поле DC | Значение | Язык |
---|---|---|
dc.contributor.author | Strekalova, T. | en |
dc.contributor.author | Svirin, E. | en |
dc.contributor.author | Waider, J. | en |
dc.contributor.author | Gorlova, A. | en |
dc.contributor.author | Cespuglio, R. | en |
dc.contributor.author | Kalueff, A. | en |
dc.contributor.author | Pomytkin, I. | en |
dc.contributor.author | Schmitt-Boehrer, A. G. | en |
dc.contributor.author | Lesch, K. -P. | en |
dc.contributor.author | Anthony, D. C. | en |
dc.date.accessioned | 2022-05-12T08:13:30Z | - |
dc.date.available | 2022-05-12T08:13:30Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Altered Behaviour, Dopamine and Norepinephrine Regulation in Stressed Mice Heterozygous in TPH2 Gene / T. Strekalova, E. Svirin, J. Waider et al. // Progress in Neuro-Psychopharmacology and Biological Psychiatry. — 2021. — Vol. 108. — 110155. | en |
dc.identifier.issn | 0278-5846 | - |
dc.identifier.other | All Open Access, Hybrid Gold | 3 |
dc.identifier.uri | http://elar.urfu.ru/handle/10995/111134 | - |
dc.description.abstract | Gene-environment interaction (GxE) determines the vulnerability of an individual to a spectrum of stress-related neuropsychiatric disorders. Increased impulsivity, excessive aggression, and other behavioural characteristics are associated with variants within the tryptophan hydroxylase-2 (Tph2) gene, a key enzyme in brain serotonin synthesis. This phenotype is recapitulated in naïve mice with complete, but not with partial Tph2 inactivation. Tph2 haploinsufficiency in animals reflects allelic variation of Tph2 facilitating the elucidation of respective GxE mechanisms. Recently, we showed excessive aggression and altered serotonin brain metabolism in heterozygous Tph2-deficient male mice (Tph2+/−) after predator stress exposure. Here, we sought to extend these studies by investigating aggressive and anxiety-like behaviours, sociability, and the brain metabolism of dopamine and noradrenaline. Separately, Tph2+/− mice were examined for exploration activity in a novel environment and for the potentiation of helplessness in the modified swim test (ModFST). Predation stress procedure increased measures of aggression, dominancy, and suppressed sociability in Tph2+/− mice, which was the opposite of that observed in control mice. Anxiety-like behaviour was unaltered in the mutants and elevated in controls. Tph2+/− mice exposed to environmental novelty or to the ModFST exhibited increased novelty exploration and no increase in floating behaviour compared to controls, which is suggestive of resilience to stress and despair. High-performance liquid chromatography (HPLC) revealed significant genotype-dependent differences in the metabolism of dopamine, and norepinephrine within the brain tissue. In conclusion, environmentally challenged Tph2+/− mice exhibit behaviours that resemble the behaviour of non-stressed null mutants, which reveals how GxE interaction studies can unmask latent genetically determined predispositions. © 2020 The Authors. | en |
dc.description.sponsorship | The authors' work reported here was supported by Deutsche Forschungsgemeinschaft (DFG:CRC TRR58A1/A5), DAAD (to ES), the European Union's Seventh Framework Programme (FP7/2007–2013) under Grant No.602805 (Aggressotype) and the Horizon 2020 Research and Innovation Programme under Grant No.728018 (Eat2beNICE) (to KPL and TS) and the President's program of PhD Exchange of RF-2017 (to TS and DA). We appreciate the valuable technical help of Natalia Bazhenova, Drs. Alexander Trofimov and Natalia Markova with this project. | en |
dc.format.mimetype | application/pdf | en |
dc.language.iso | en | en |
dc.publisher | Elsevier Inc. | en1 |
dc.publisher | Elsevier BV | en |
dc.rights | info:eu-repo/semantics/openAccess | en |
dc.source | Prog. Neuro-Psychopharmacol. Biol. Psychiatry | 2 |
dc.source | Progress in Neuro-Psychopharmacology and Biological Psychiatry | en |
dc.subject | AGGRESSION | en |
dc.subject | DOPAMINE | en |
dc.subject | MOUSE | en |
dc.subject | NORADRENALINE | en |
dc.subject | STRESS | en |
dc.subject | TRYPTOPHAN HYDROXYLASE-2 (TPH2) | en |
dc.subject | DOPAMINE | en |
dc.subject | NORADRENALIN | en |
dc.subject | PENTOBARBITAL | en |
dc.subject | SEROTONIN | en |
dc.subject | SODIUM CHLORIDE | en |
dc.subject | TRYPTOPHAN HYDROXYLASE 2 | en |
dc.subject | DOPAMINE | en |
dc.subject | NORADRENALIN | en |
dc.subject | TPH2 PROTEIN, MOUSE | en |
dc.subject | TRYPTOPHAN HYDROXYLASE | en |
dc.subject | AGGRESSION | en |
dc.subject | AMYGDALA | en |
dc.subject | ANESTHESIA | en |
dc.subject | ANIMAL EXPERIMENT | en |
dc.subject | ANIMAL MODEL | en |
dc.subject | ANTIDEPRESSANT ACTIVITY | en |
dc.subject | ARTICLE | en |
dc.subject | BEHAVIOR | en |
dc.subject | BODY MOVEMENT | en |
dc.subject | BRAIN CORTEX | en |
dc.subject | CONTROLLED STUDY | en |
dc.subject | CORPUS STRIATUM | en |
dc.subject | DOPAMINE METABOLISM | en |
dc.subject | ELECTROCHEMISTRY | en |
dc.subject | EXPERIMENTAL BEHAVIORAL TEST | en |
dc.subject | GENOTYPE | en |
dc.subject | GENOTYPE ENVIRONMENT INTERACTION | en |
dc.subject | HAPLOINSUFFICIENCY | en |
dc.subject | HEAD MOVEMENT | en |
dc.subject | HETEROZYGOTE | en |
dc.subject | HIGH PERFORMANCE LIQUID CHROMATOGRAPHY | en |
dc.subject | HIPPOCAMPUS | en |
dc.subject | ILLUMINATION | en |
dc.subject | IMMUNOREACTIVITY | en |
dc.subject | IMPULSIVENESS | en |
dc.subject | MALE | en |
dc.subject | MENTAL DISEASE | en |
dc.subject | METABOLISM | en |
dc.subject | NONHUMAN | en |
dc.subject | PHENOTYPE | en |
dc.subject | PHYSIOLOGICAL STRESS | en |
dc.subject | PREDATION | en |
dc.subject | RAT | en |
dc.subject | ANIMAL | en |
dc.subject | GENETICS | en |
dc.subject | MENTAL STRESS | en |
dc.subject | PSYCHOLOGY | en |
dc.subject | SOCIAL BEHAVIOR | en |
dc.subject | TRANSGENIC MOUSE | en |
dc.subject | WISTAR RAT | en |
dc.subject | ANIMALS | en |
dc.subject | BRAIN | en |
dc.subject | DOPAMINE | en |
dc.subject | MICE | en |
dc.subject | MICE, TRANSGENIC | en |
dc.subject | NOREPINEPHRINE | en |
dc.subject | RATS | en |
dc.subject | RATS, WISTAR | en |
dc.subject | SOCIAL BEHAVIOR | en |
dc.subject | STRESS, PSYCHOLOGICAL | en |
dc.subject | TRYPTOPHAN HYDROXYLASE | en |
dc.title | Altered Behaviour, Dopamine and Norepinephrine Regulation in Stressed Mice Heterozygous in TPH2 Gene | en |
dc.type | Article | en |
dc.type | info:eu-repo/semantics/article | en |
dc.type | info:eu-repo/semantics/publishedVersion | en |
dc.identifier.rsi | 45178652 | - |
dc.identifier.doi | 10.1016/j.pnpbp.2020.110155 | - |
dc.identifier.scopus | 85095992892 | - |
local.contributor.employee | Strekalova, T., Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands, Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation, Division of Molecular Psychiatry, Centre of Mental Health, University of Würzburg, Würzburg, Germany; Svirin, E., Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands, Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation, Division of Molecular Psychiatry, Centre of Mental Health, University of Würzburg, Würzburg, Germany; Waider, J., Division of Molecular Psychiatry, Centre of Mental Health, University of Würzburg, Würzburg, Germany; Gorlova, A., Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands, Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation; Cespuglio, R., Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation, Neurocampus Michel Jouvet, VELIB Plateau, Claude-Bernard Lyon-1 University, Lyon, France; Kalueff, A., Laboratory of Cell and Molecular Biology and Neurobiology, Moscow Institute of Physics and Technology, Dolgoprudny, Russian Federation, Institute of Translational Biomedicine, St. Petersburg State, University, St. Petersburg, Russian Federation, Ural Federal University, Ekaterinburg, Russian Federation; Pomytkin, I., Center for Advanced Cell Technologies, Institute of Regenerative Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation; Schmitt-Boehrer, A.G., Division of Molecular Psychiatry, Centre of Mental Health, University of Würzburg, Würzburg, Germany; Lesch, K.-P., Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands, Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation, Division of Molecular Psychiatry, Centre of Mental Health, University of Würzburg, Würzburg, Germany; Anthony, D.C., Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation, Department of Pharmacology, Oxford University, Oxford, United Kingdom | en |
local.volume | 108 | - |
dc.identifier.wos | 000643709100003 | - |
local.contributor.department | Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands; Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation; Division of Molecular Psychiatry, Centre of Mental Health, University of Würzburg, Würzburg, Germany; Neurocampus Michel Jouvet, VELIB Plateau, Claude-Bernard Lyon-1 University, Lyon, France; Laboratory of Cell and Molecular Biology and Neurobiology, Moscow Institute of Physics and Technology, Dolgoprudny, Russian Federation; Institute of Translational Biomedicine, St. Petersburg State, University, St. Petersburg, Russian Federation; Ural Federal University, Ekaterinburg, Russian Federation; Center for Advanced Cell Technologies, Institute of Regenerative Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation; Department of Pharmacology, Oxford University, Oxford, United Kingdom | en |
local.identifier.pure | 21882765 | - |
local.description.order | 110155 | - |
local.identifier.eid | 2-s2.0-85095992892 | - |
local.fund.cordis | H020: 728018 | - |
local.identifier.wos | WOS:000643709100003 | - |
local.identifier.pmid | 33127424 | - |
Располагается в коллекциях: | Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC |
Файлы этого ресурса:
Файл | Описание | Размер | Формат | |
---|---|---|---|---|
2-s2.0-85095992892.pdf | 1,71 MB | Adobe PDF | Просмотреть/Открыть |
Все ресурсы в архиве электронных ресурсов защищены авторским правом, все права сохранены.